RachelB.WagmanMDFACE, FACP

Diabetes, Lipid Metabolism, Osteoporosis & Bone Metabolism Medicine

Operational Vice President, Clinical Research

Dr. Wagman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
Sumitomo Pharma America
2000 Sierra Point Parkway STE 900
Brisbane, CA 94005
Phone+1 650-534-4783

Stanford Health Care-Sponsored Stanford UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 2000 - 2002
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 1997 - 2000
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1997
University of PennsylvaniaBA, History, Distinction in History, 1989 - 1993

PubMed

6 citations
Two-year efficacy and safety of relugolix combination therapy in women with endometriosis-associated pain: SPIRIT open-label extension study.
Christian M Becker, Neil P Johnson, Sawsan As-Sanie, Juan C Arjona Ferreira, Mauricio S Abrao
Human Reproduction. 2024-03-01
6 citations
LIBERTY randomized withdrawal study: relugolix combination therapy for heavy menstrual bleeding associated with uterine fibroids.
Ayman Al-Hendy, Roberta Venturella, Juan Camilo Arjona Ferreira, Yulan Li, Graziella Soulban
American Journal of Obstetrics and Gynecology. 2023-12-01
1 citations
A Plain Language Summary to learn about relugolix combination therapy for the treatment of pain associated with endometriosis.
Linda C Giudice, Sawsan As-Sanie, Juan C Arjona Ferreira, Christian M Becker, Mauricio S Abrao
Pain Management. 2023-11-01

Single BMD and Fracture Hx May Predict Risk of Fracture in Postmenopausal WomenAugust 28th, 2017
Single BMD and Fracture Hx May Predict Risk of Fracture in Postmenopausal WomenAugust 28th, 2017